Michael Walter

Michael Walter
Managing Editor


Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

LATEST ARTICLES BY THIS AUTHOR

Roche spends $2.7B to acquire biotech company with multiple obesity, diabetes drugs in development
FDA approves early feasibility study for total artificial heart technology
New AFib guidelines include higher recommendations for catheter ablation, LAAO
First US patient treated with Medtronic’s FDA-approved renal denervation system
‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful
Johnson & Johnson acquires medical device company behind new LAA technology for $400M
Cardiologist receives $7M for 5-year study to boost care for heart failure patients
Avidity Biosciences inks drug discovery deal worth up to $2.3B with industry heavyweight
Robotic-assisted CABG reduces healthcare costs, primarily thanks to shorter hospital stays
New formula could mean diabetes and weight loss drugs such as semaglutide are only needed every 4 months